What does UnitedHealth Group do and what are its main business segments?

What is the market's earnings forecast for UnitedHealth Group next quarter?

What factors drove the changes in UnitedHealth Group's revenue and profit?

Did UnitedHealth Group beat or miss consensus estimates last quarter?

What is UnitedHealth Group's latest dividend and current dividend yield?

What were the key takeaways from UnitedHealth Group’s earnings call?

What guidance did UnitedHealth Group's management provide for the next earnings period?

What were the key takeaways from UnitedHealth Group's earnings call?

- **2026 Growth Target**: Adjusted EPS >$17.75 (8.6% growth), with UnitedHealthcare leading the charge.
- **Medicare Risk**: 1.3-1.4M MA contraction in 2026, but 50bps margin recovery via repricing.
- **Optum Turnaround**: OptumRx +2% growth, OptumInsight +90bps margin, OptumHealth +30bps via AI.
- **AI Investment**: $1.5B+ in 2026 to unlock $1B+ cost savings and customer experience gains.
- **Risks**: Medicaid funding shortfall, Medicare rate cuts, and commercial trend persistence.
- **Long-Term Vision**: 6-8% OptumHealth margins, 13-16% EPS growth, and AI-driven health system transformation.

**【CEO Summary Section】**
- UnitedHealth Group reported adjusted EPS of $16.35 for 2025, slightly ahead of expectations, with a $1.6 billion non-cash charge impacting the quarter.
- 2026 outlook: Adjusted EPS >$17.75 (8.6% growth), driven by double-digit growth in UnitedHealthcare and low to high single-digit gains in Optum segments.
- Emphasis on AI investment ($1.5B+ in 2026), operational discipline, and strategic portfolio realignment (e.g., Optum Financial Services integration with OptumInsight).
- Medicare Advantage contraction of 1.3-1.4M members in 2026 due to funding cuts, with margin improvement of 50bps expected.

**【CFO Financial Commentary】**
- 2025 revenue: $448B (12% YoY growth), medical care ratio 89.1%, operating cost ratio 13.3%.
- 2026 guidance: Revenues ~$440B, adjusted EPS >$17.75, medical care ratio 88.8% ±50bps, operating cost ratio 12.8% ±50bps.
- Strong cash flow ($19.7B in 2025) supporting dividend and debt reduction to 40% target by year-end.

**【UnitedHealthcare Business Highlights】**
- Medicare: 2025 trend 7.5%, 2026 expected 10% due to elevated utilization; margin improvement 50bps via repricing and contraction.
- Medicaid: 2026 membership decline 565K-715K, rate relief insufficient to offset acuity; 2027 hopes for improvement.
- Commercial: 13% adjusted operating earnings growth, 40bps margin expansion via repricing and AI-driven cost savings ($1B+ in 2026).

**【Optum Segment Performance】**
- OptumRx: 800+ new clients offset UHC contraction, 20bps margin expansion via AI automation and rebate pass-through (95%+ clients in 2026).
- OptumInsight: >4% growth, 90bps margin expansion via AI innovation (e.g., real-time payment solutions) and Optum Financial Services alignment.
- OptumHealth: 9% earnings growth, 30bps margin expansion via network optimization (20% reduction in affiliated providers), risk portfolio reshaping, and EMR standardization.

**【Q&A Key Themes】**
- Medicare Advantage: 2027 rate notice disappointment (1.8% normalization, 3.3% headwind), potential further contraction in 2027.
- OptumHealth: 2026 margin improvement via execution (e.g., Texas market 30% cost savings), targeting 6-8% long-term margins.
- Medicaid: 2026 rate increases 6-7% vs. 10%+ trend, continued pressure until 2027.
- AI/Technology: $1.5B+ investment in 2026 to drive efficiency (e.g., 80% of calls resolved via AI tools).

UnitedHealth Group Incorporated (UNH) Q4 2025 Earnings Call Transcript

- **Revenue Growth**: Q3 revenue up 12% YoY to $113B, driven by membership expansion and pricing actions. 
- **Margin Recovery**: 2026 Commercial margins to improve by 150bps, Medicare margins to stabilize post-V28 cuts. 
- **Optum Restructuring**: 200K PPO exits, 10% VBC membership decline in 2026, targeting 6-8% Optum Health margins by 2027. 
- **AI Innovation**: Optum Insight launching AI-first tools with 13:1 ROI in Crimson AI, positioning for long-term growth. 
- **Challenges**: $6B+ V28 headwind in 2026, Medicaid margin trough in 2026, and elevated medical trends across segments.

**【CEO Summary Section】**
- CEO Stephen Hemsley emphasized progress in addressing underperformance, including network reductions, pricing adjustments, and AI investments. 
- UnitedHealthcare (UHC) medical cost trends remain elevated at 7.5% for Medicare Advantage, with 2026 pricing actions targeting margin improvement. 
- Optum Health is refocusing on value-based care (VBC) with narrower networks and exits from 200,000 PPO lives, aiming for 10% membership decline in 2026. 
- CFO Wayne DeVeydt highlighted Q3 adjusted EPS of $2.92, medical care ratio of 89.9%, and $450M+ investments in employee incentives and community programs. 
- 2026 outlook includes $6B+ headwind from V28 cuts, but expects margin recovery in Commercial and Medicare businesses. 

**【CFO Financial Commentary】**
- Q3 revenue: $113B (12% YoY growth), operating cash flow: $5.9B, debt-to-capital ratio: 44.1%. 
- UHC medical cost trends: 11% for commercial, 7.5% for Medicare, 11%+ for Med Sup. 
- Optum Health margins: ~3% in 2025, targeting 6-8% by 2027. 
- Capital deployment paused for debt reduction, with potential resumption of buybacks in 2H26. 

**【Q&A Key Highlights】**
- **Optum Health Restructuring**: 10% VBC membership decline in 2026, 90%+ of 2026 VBC contracts renegotiated to offset V28 headwinds. 
- **Medicaid Challenges**: 2026 margins expected to decline due to funding gaps, targeting 2%+ margins by 2028. 
- **AI Investments**: Optum Insight launching AI-first products (e.g., Optum Real, Integrity One), with 13:1 ROI in Crimson AI. 
- **Provider Coding Trends**: Higher DRG weighting and specialist involvement driving 11%+ trend in commercial business. 
- **Shareholder Returns**: Dividend policy unchanged; buybacks and M&A on hold until debt ratio <40%.

UnitedHealth Group Incorporated (UNH) Q3 2025 Earnings Call Transcript

- **Medical Cost Crisis:** UHC faces $6.5B shortfall due to 7.5% Medicare trend (vs. 5% bid) and 11% commercial trend. Optum VBC margins at 1% (2025) due to V28 cuts and enrollment mix.
- **2026 Pricing Reset:** UHC MA 2026 bids assume 10% trend, targeting 2.5%-3% margins. OptumRx Nuvaila to drive affordability and specialty drug growth.
- **AI and Digital Transformation:** $1B+ investments in AI for care management, claims processing, and consumer engagement. OptumInsight launching AI-powered solutions for 2025.
- **Strategic Shifts:** Exit 600K Medicare members in PPO plans. Optum scaling AI to reduce costs by $1B in 2026. Full-year 2025 medical care ratio 89.25%.

**【CEO Summary Section】**
- CEO Steve Hemsley emphasized a cultural shift towards transparency, accountability, and mission-driven reform. The company is addressing challenges in medical cost trends, regulatory pressures, and operational inefficiencies.
- UnitedHealthcare (UHC) reported a $6.5 billion medical cost shortfall due to underestimated trends in Medicare, commercial, and Medicaid segments. UHC is exiting 600,000 Medicare members in less managed products and tightening network controls.
- Optum faces $6.6 billion earnings shortfall in value-based care (VBC) due to V28 funding cuts, enrollment mix, and medical trend acceleration. Optum aims to recover margins by 2027 through rate adjustments, benefit redesign, and AI-driven efficiency.

**【CFO Financial Commentary】**
- Q2 2025 revenue: $112 billion (13% YoY growth). Adjusted EPS: $4.08 (down 12% YoY) due to medical cost pressures. Full-year 2025 guidance: EPS $16+, revenue $448 billion (11% growth), medical care ratio 89.25%.
- UHC Medicare Advantage (MA) margin target for 2026: 2.5%-3% (vs. 2025: 2%-2.5%). Commercial margin recovery expected in 2026, targeting 7%-9% range by 2027.
- OptumRx revenue growth: $38.5 billion (19% YoY), driven by specialty drugs. Nuvaila private-label business faces $150M headwind but expected to improve affordability and margins.

**【Q&A Highlights】**
- **Margin Recovery:** UHC MA 2026 pricing assumes 10% trend, with 50% of V28 headwinds offset by rate increases and benefit cuts. Optum VBC 2026 margin: 1% (same as 2025), improving to 5%+ by 2027.
- **Investments:** $1B+ in AI and digital tools across UHC and Optum. OptumInsight to focus on AI-powered RCM and real-time benefits coordination.
- **Strategic Reviews:** Portfolio actions paused to refocus on core business performance. Amedisys acquisition expected to enhance home care capabilities for VBC.


UnitedHealth Group Incorporated (UNH) Q2 2025 Earnings Call Transcript

- **EPS Guidance Adjustment**: 2025 adjusted EPS revised to $26-$26.50 due to Medicare utilization and member profile challenges.
- **MA Care Activity Surge**: Q1 2025 MA care activity doubled 2024 rate, driven by premium increases and wellness visits.
- **Optum Health Struggles**: $100M+ revenue shortfall from new Medicare patients and CMS risk model execution issues.
- **2026 Outlook**: MA bids will reflect 2025 trend persistence; Optum Health to add 650K value-based patients.
- **Policy Risks**: Arkansas PBM law threatens specialty pharmacy access; federal pharmacy EO expected to address full value chain.

**【CEO Summary Section】**
- UnitedHealth Group revised its 2025 adjusted EPS outlook to $26-$26.50 due to higher-than-expected care activity in Medicare Advantage (MA) and Optum Health member profile challenges.
- MA care activity increased at twice the 2024 rate, driven by physician and outpatient services. Optum Health faced lower-than-expected reimbursement from new Medicare patients and CMS risk model execution issues.
- The company plans to address these challenges through enhanced member engagement (e.g., HouseCalls program), clinical workflow improvements, and 2026 MA plan pricing adjustments.
- Despite challenges, UHC expects to add 800,000 new MA members in 2025, while Optum Health aims to add 650,000 value-based care patients.

**【CFO Financial Commentary】**
- Q1 2025 GAAP net income: $4.2 billion; Non-GAAP EPS: $1.08 (vs. $0.95 prior guidance).
- Full-year medical care ratio (MLR) expected at 87.5% ±50bps, up from 86.5% in 2024, due to higher utilization.
- Optum Health revenue outlook revised to $10.6-$10.7 billion (down from $11.2 billion) due to member profile and CMS model issues.
- UnitedHealthcare operating earnings: $16-$16.5 billion (up from $15.5 billion prior guidance) reflecting MA volume growth.
- OptumRx revenue grew 14% Q1, with 3% script growth driven by customer retention and new wins.

**【Q&A Key Themes】**
- **MA Cost Trend**: Q1 MLR increase of ~200bps due to 2x higher care activity vs. 2024. Group MA premium increases (e.g., $50 to $200) drove unexpected utilization. 2026 MA bids will incorporate 2025 trend persistence.
- **Optum Health Challenges**: New Medicare patients with low engagement (e.g., Texas, Washington exits) and CMS V28 risk model execution issues. 2025 actions include accelerated EMR unification and post-discharge care expansion.
- **Policy Risks**: Arkansas PBM ownership law could disrupt specialty pharmacy access. Company expects federal pharmacy EO to focus on full value chain reform.
- **Medicaid Progress**: Rate acuity gap narrowing with states, with 35% of 2025 renewals in July. UHC remains focused on value-based care innovation.
- **Long-Term Growth**: Confident in 13-16% EPS growth target post-2026, as CMS rate notice reflects care cost trends and V28 transition completion.

UnitedHealth (UNH)-17 Apr 25-2025 Q1 Earnings call transcript

- **2024 Performance**: $400B revenue, $27.66 EPS, within guidance despite $6B+ headwinds from CMS cuts and cyberattack.
- **2025 Outlook**: 86.5% MLR, 10%+ revenue growth, 800K MA additions, and 100% PBM rebate transparency by 2028.
- **Key Drivers**: AI reduces costs (10% fewer calls), value-based care (5.4M patients), and PBM savings ($90B+ annually).
- **Risks**: Medicaid rate lag, drug price inflation, and regulatory uncertainty.


**【CEO Opening Remarks】**
- UnitedHealth Group achieved 2024 revenue of over $400 billion and adjusted EPS of $27.66, within the guided range despite challenges like CMS rate cuts and the Change Healthcare cyberattack.
- Emphasized the company's mission to improve healthcare outcomes through value-based care, digital tools, and AI-driven efficiency.
- Highlighted Medicare Advantage growth (800,000 new members in 2025) and the importance of reducing healthcare costs through PBM rebate transparency.

**【CFO Financial Overview】**
- 2024 medical care ratio (MLR) was 86.0%, up 150bps YoY due to higher specialty drug costs, coding intensity, and Medicaid mix shifts.
- 2025 MLR expected at 86.5% ±50bps, driven by IRA impacts, CMS rate cuts, and public sector mix shift.
- Operating cost ratio improved 150bps YoY, with half from portfolio changes and half from AI-driven efficiency gains.
- 2025 revenue growth of 10%+ across segments, with Optum Health targeting 5.4M value-based patients and OptumRx $146B in PBM revenue.

**【Q&A Highlights】**
- **MLR Volatility**: 2024 MLR volatility due to one-time cyberattack costs ($1B) and Medicaid rate lag; 2025 outlook assumes normalized trends.
- **PBM Reform**: Committing to 100% rebate pass-through by 2028, with 98% already passed in 2024; defends PBM role in lowering drug prices ($900 vs $90 in GLP-1s).
- **MA Growth**: 2025 MA growth of 800K (50% from AEP), targeting 70%+ penetration; 3x more returning members than 2024.
- **AI Impact**: 10% fewer customer service calls YoY; scaling AI tools to reduce administrative costs and improve care coordination.


Actual																3.72	7.12	3.51	2.52	5.31	4.7	4.52	4.48	5.49	5.57	5.79	5.34	6.26	6.14	6.56	6.16	6.91	6.8	7.15	6.81	7.2	4.08	2.92	2.11
Forecast																3.626	5.2763	3.1063	2.4071	4.392	4.4328	4.4153	4.3055	5.3721	5.2053	5.4293	5.1728	6.1639	5.9908	6.3341	5.9847	6.6062	6.6483	7.0052	6.7379	7.2917	4.4502	2.7954	2.11	6.6531
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+2.59%	+34.94%	+13.00%	+4.69%	+20.90%	+6.03%	+2.37%	+4.05%	+2.19%	+7.01%	+6.64%	+3.23%	+1.56%	+2.49%	+3.57%	+2.93%	+4.60%	+2.28%	+2.07%	+1.07%	-1.26%	-8.32%	+4.46%	0.00%	0.00%

Actual	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	64.42B	62.14B	65.11B	65.47B	70.20B	71.32B	72.34B	73.74B	80.15B	80.33B	80.89B	82.79B	91.93B	92.90B	92.36B	94.43B	99.80B	98.86B	100.82B	100.81B	109.58B	111.62B	113.16B	113.22B	--
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	64.16B	63.48B	63.79B	64.96B	69.07B	69.51B	71.38B	72.98B	78.73B	79.68B	80.52B	82.48B	89.71B	90.97B	91.41B	92.13B	99.22B	98.79B	99.14B	101.60B	111.58B	111.52B	113.03B	113.77B	109.58B
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+0.40%	-2.12%	+2.08%	+0.78%	+1.63%	+2.61%	+1.34%	+1.04%	+1.81%	+0.82%	+0.46%	+0.37%	+2.48%	+2.13%	+1.04%	+2.50%	+0.58%	+0.07%	+1.70%	-0.78%	-1.80%	+0.08%	+0.12%	-0.49%	0.00%

UNH

UNH fundamentals

UNH Q1 2026 Earnings Preview

Earnings Call

You can ask Aime

UNH

UNH fundamentals

UNH Q1 2026 Earnings Preview

Earnings Call

UNH Earnings Call Summary for Q1/2026Upcoming8:00 AM on Apr 21, 2026

UNH Earnings Call Summary for Q4/20258:00 AM on Jan 27, 2026

UNH Earnings Call Summary for Q3/20258:00 AM on Oct 28, 2025

UNH Earnings Call Summary for Q2/20258:00 AM on Jul 29, 2025

UNH Earnings Call Summary for Q1/20258:45 AM on Apr 17, 2025

You can ask Aime